gemcitabine has been researched along with apicidin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, R; Ansari, D; Bauden, MP; Ek, F; Hilmersson, KS; Olsson, R; Urey, C | 1 |
1 other study(ies) available for gemcitabine and apicidin
Article | Year |
---|---|
Apicidin sensitizes pancreatic cancer cells to gemcitabine by epigenetically regulating MUC4 expression.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Gemcitabine; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Mucin-4; Pancreatic Neoplasms; Peptides, Cyclic; Small Molecule Libraries | 2014 |